These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34445377)

  • 1. Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis.
    Chen JH; Wu CH; Chiang CK
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases.
    Ryno LM; Wiseman RL; Kelly JW
    Curr Opin Chem Biol; 2013 Jun; 17(3):346-52. PubMed ID: 23647985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of endoplasmic reticulum (ER) stress in gliomas.
    Markouli M; Strepkos D; Papavassiliou AG; Piperi C
    Pharmacol Res; 2020 Jul; 157():104823. PubMed ID: 32305494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury.
    Yan M; Shu S; Guo C; Tang C; Dong Z
    Ann Med; 2018 Aug; 50(5):381-390. PubMed ID: 29895209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.
    Obacz J; Avril T; Le Reste PJ; Urra H; Quillien V; Hetz C; Chevet E
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum proteostasis control and gastric cancer.
    Wang Y; Wang K; Jin Y; Sheng X
    Cancer Lett; 2019 May; 449():263-271. PubMed ID: 30776479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Folding and the Challenges of Maintaining Endoplasmic Reticulum Proteostasis in Idiopathic Pulmonary Fibrosis.
    Romero F; Summer R
    Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S410-S413. PubMed ID: 29161089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.
    Inagi R; Ishimoto Y; Nangaku M
    Nat Rev Nephrol; 2014 Jul; 10(7):369-78. PubMed ID: 24752014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum proteostasis: a key checkpoint in cancer.
    Oakes SA
    Am J Physiol Cell Physiol; 2017 Feb; 312(2):C93-C102. PubMed ID: 27856431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis.
    Kolb PS; Ayaub EA; Zhou W; Yum V; Dickhout JG; Ask K
    Int J Biochem Cell Biol; 2015 Apr; 61():45-52. PubMed ID: 25660369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum proteostasis impairment in aging.
    Martínez G; Duran-Aniotz C; Cabral-Miranda F; Vivar JP; Hetz C
    Aging Cell; 2017 Aug; 16(4):615-623. PubMed ID: 28436203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases.
    Cybulsky AV
    Nat Rev Nephrol; 2017 Nov; 13(11):681-696. PubMed ID: 28970584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unfolded protein response as a target for anticancer therapeutics.
    Wang M; Law ME; Castellano RK; Law BK
    Crit Rev Oncol Hematol; 2018 Jul; 127():66-79. PubMed ID: 29891114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
    Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
    Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
    Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
    EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecules to Improve ER Proteostasis in Disease.
    Gonzalez-Teuber V; Albert-Gasco H; Auyeung VC; Papa FR; Mallucci GR; Hetz C
    Trends Pharmacol Sci; 2019 Sep; 40(9):684-695. PubMed ID: 31377018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER proteostasis addiction in cancer biology: Novel concepts.
    Dufey E; Urra H; Hetz C
    Semin Cancer Biol; 2015 Aug; 33():40-7. PubMed ID: 25931388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological Role of Organelle Stress/Crosstalk in AKI-to-CKD Transition.
    Maekawa H; Inagi R
    Semin Nephrol; 2019 Nov; 39(6):581-588. PubMed ID: 31836040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (off)Targeting UPR signaling: the race toward intervening ER proteostasis.
    Pérez-Arancibia R; Rivas A; Hetz C
    Expert Opin Ther Targets; 2018 Feb; 22(2):97-100. PubMed ID: 29260915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.